SEC Form 4 · accession 0001645627-17-000066
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 18, 2017
Accepted (ET)
May 22, 2017 · 1:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 18, 2017 | P | 1,000 | $0.062 | A | 20,847,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.062 | A | 20,848,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.062 | A | 20,849,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.058 | A | 20,850,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.0577 | A | 20,851,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.058 | A | 20,852,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.058 | A | 20,853,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.0577 | A | 20,854,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.0549 | A | 20,855,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.0525 | A | 20,856,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.0525 | A | 20,857,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.0519 | A | 20,858,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.052 | A | 20,859,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.052 | A | 20,860,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.052 | A | 20,861,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.052 | A | 20,862,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.0546 | A | 20,863,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.055 | A | 20,864,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.0569 | A | 20,865,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.057 | A | 20,866,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.057 | A | 20,867,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.057 | A | 20,868,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.0568 | A | 20,869,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.0569 | A | 20,870,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.0569 | A | 20,871,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.0569 | A | 20,872,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.0568 | A | 20,873,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.0568 | A | 20,874,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.0565 | A | 20,875,949 | D | |
| Common Stock | May 18, 2017 | P | 1,000 | $0.0565 | A | 20,876,949 | D |
Table II — derivative securities
No Table II lines on this filing.